Docetaxel
BEIZRAY, DOCIVYX, Docetaxel
Microtubule Inhibitor
NADAC/unit
N/A
No Shortage
11 Manufacturers
31 ANDAs
Active Shortages
2026-02-20 A business decision was made to discontinue manufacture of the drug., Ingenus Pharmaceuticals LLC
2026-02-20 A business decision was made to discontinue manufacture of the drug., Ingenus Pharmaceuticals LLC
2025-06-24 Discontinuation of the manufacture of the drug, Pfizer Inc.
2025-06-24 Discontinuation of the manufacture of the drug, Pfizer Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCACTAVIS LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INCALEMBIC PHARMACEUTICALS LTDAMNEAL EU LTDAVYXA HOLDINGS LLCDR REDDYS LABORATORIES LTDGLAND PHARMA LTDGUANGDONG SUNHO PHARMACEUTICAL CO LTDHERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INCHIKMA FARMACEUTICA PORTUGAL SAHOSPIRA INCJIANGSU HENGRUI PHARMACEUTICALS CO LTDMEITHEAL PHARMACEUTICALS INCMYLAN LABORATORIES LTDSANDOZSANOFI AVENTIS US LLCSHILPA MEDICARE LTDZHUHAI BEIHAI BIOTECH CO LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.